A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Semaglutide, used for diabetes and obesity, may reduce alcohol cravings in adults with alcohol use disorder, offering a potential solution to a major treatment gap.
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.
The popular weight loss and diabetes drug semaglutide could also reduce alcohol cravings, drinking quantity and the frequency ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol ...
The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...
The first clinical trial of its kind found the weekly semaglutide jab cuts the amount people drink in one day by 40 per cent ...
Wegovy: sales of weight loss injection more than double - The company said more than 45 million people were now ‘benefitting ...
A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback